Target type: biologicalprocess
The chemical reactions and pathways resulting in the breakdown of acylglycerol, any mono-, di- or triester of glycerol with (one or more) fatty acids. [GOC:ai]
Acylglycerol catabolic process is the breakdown of acylglycerols, which are lipids composed of glycerol and fatty acids. This process is essential for energy production and the recycling of fatty acids. The process begins with the hydrolysis of acylglycerols, catalyzed by lipases, to produce glycerol and free fatty acids. Glycerol can then be used in various metabolic pathways, including glycolysis and gluconeogenesis, to generate ATP. Free fatty acids can be oxidized through beta-oxidation to produce acetyl-CoA, which enters the citric acid cycle for further energy production. Acylglycerol catabolism also plays a crucial role in lipid homeostasis. When the body has excess energy, it stores it as triglycerides, which are acylglycerols containing three fatty acids. During periods of fasting or exercise, triglycerides are broken down to provide energy. Acylglycerol catabolism is also important for the synthesis of various bioactive molecules, such as prostaglandins, thromboxanes, and leukotrienes, which play roles in inflammation, blood clotting, and immune responses.'
"
Protein | Definition | Taxonomy |
---|---|---|
Monoacylglycerol lipase ABHD6 | A monoacylglycerol lipase ABHD6 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9BV23] | Homo sapiens (human) |
Monoglyceride lipase | A monoglyceride lipase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q99685] | Homo sapiens (human) |
Lysophosphatidylserine lipase ABHD12 | A lysophosphatidylserine lipase ABHD12 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8N2K0] | Homo sapiens (human) |
Acyl-protein thioesterase 2 | An acyl-protein thioesterase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O95372] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
benzo(b)thiophene-2-boronic acid | benzo(b)thiophene-2-boronic acid: inhibits AmpC beta-lactamase; structure in first source | ||
disulfiram | organic disulfide; organosulfur acaricide | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor | |
ethylmaleimide | Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies. | maleimides | anticoronaviral agent; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.1.1 (hexokinase) inhibitor |
1,6-bis(cyclohexyloximinocarbonyl)hexane | 1,6-bis(cyclohexyloximinocarbonyl)hexane: selective inhibitor of canine platelet diglyceride lipase | carbamate ester; organonitrogen compound | |
thiram | thiram : An organic disulfide that results from the formal oxidative dimerisation of N,N-dimethyldithiocarbamic acid. It is widely used as a fungicidal seed treatment. Thiram: A dithiocarbamate chemical, used commercially in the rubber processing industry and as a fungicide. In vivo studies indicate that it inactivates the enzyme GLUTATHIONE REDUCTASE. It has mutagenic activity and may induce chromosomal aberrations. | organic disulfide | antibacterial drug; antifungal agrochemical; antiseptic drug |
bis(1-piperidylthiocarbonyl)disulfide | bis(1-piperidylthiocarbonyl)disulfide: indicator for analysis of copper; structure | ||
tetramethylthiuram monosulfide | |||
4,4'-dithiodimorpholine | 4,4'-dithiodimorpholine: rubber vulcanizing agent causing occupational dermatitis; structure | ||
methyl diethyldithiocarbamate | |||
diphenyl disulfide | benzenes | ||
n-phenylmaleimide | N-phenylmaleimide: structure in Merck Index, 9th ed, #7104 | ||
dronabinol | Delta(9)-tetrahydrocannabinol : A diterpenoid that is 6a,7,8,10a-tetrahydro-6H-benzo[c]chromene substituted at position 1 by a hydroxy group, positions 6, 6 and 9 by methyl groups and at position 3 by a pentyl group. The principal psychoactive constituent of the cannabis plant, it is used for treatment of anorexia associated with AIDS as well as nausea and vomiting associated with cancer chemotherapy. Dronabinol: A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. | benzochromene; diterpenoid; phytocannabinoid; polyketide | cannabinoid receptor agonist; epitope; hallucinogen; metabolite; non-narcotic analgesic |
1,6-bismaleimidohexane | |||
diacerein | diacerein: chelates with bivalent metals; a quinone which possesses redox properties; metabolized to active rhein; proposed mechanisms include inhibiting IL1 and metalloproteinases; called a slow acting symptomatic drug in osteoarthritis; no effect of cyclooxygenase; | anthraquinone | |
phenylethane boronic acid | |||
benzeneboronic acid | boronic acids | ||
n-methylmaleimide | N-methylmaleimide: structure in first source | ||
n-benzylmaleimide | |||
n,n'-4-phenylenedimaleimide | |||
n-(2-methoxyphenyl)maleimide | N-(2-methoxyphenyl)maleimide: structure given in first source | ||
n-(4-bromophenyl)maleimide | N-(4-bromophenyl)maleimide: structure given in first source | ||
1,1'-biphenyl-4-yl-boronic acid | |||
4-methoxyphenylboronic acid | 4-methoxyphenylboronic acid: structure in first source | ||
orlistat | orlistat : A carboxylic ester resulting from the formal condensation of the carboxy group of N-formyl-L-leucine with the hydroxy group of (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]oxetan-2-one. A pancreatic lipase inhibitor, it is used as an anti-obesity drug. Orlistat: A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit the absorption of dietary fat; it is used in the management of obesity. | beta-lactone; carboxylic ester; formamides; L-leucine derivative | anti-obesity agent; bacterial metabolite; EC 2.3.1.85 (fatty acid synthase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor |
arachidonyltrifluoromethane | AACOCF3 : A fatty acid derivative that is arachidonic acid in which the OH part of the carboxy group has been replaced by a trifluoromethyl group arachidonyltrifluoromethane: structure given in first source; inhibits 85-kDa phospholipase A2 | fatty acid derivative; ketone; olefinic compound; organofluorine compound | EC 3.1.1.4 (phospholipase A2) inhibitor |
[2-(1-piperidinyl)-1,3-benzothiazol-6-yl]-[4-(2-pyridinyl)-1-piperazinyl]methanone | piperazines; pyridines | ||
guineensine | guineensine: an Acyl-CoA: cholesterol acyltransferase inhibitor, from the fruits of Piper longum; structure in first sourc | benzodioxoles | |
cay 10499 | carbamate ester | ||
methyl arachidonylfluorophosphonate | phosphonic ester | ||
urb602 | URB602: inhibitor of 2-arachidonoylglycerol (2-AG)-deactivating enzyme, monoacylglycerol lipase, structure in first source | ||
ly2183240 | LY2183240: structure in first source | biphenyls | |
1-(4-chlorophenyl)-3-(3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl)urea | 1-(4-chlorophenyl)-3-(3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl)urea: structure in first source | ||
omdm 169 | OMDM 169: has antinociceptive activity; structure in first source | ||
am 6701 | |||
jzl 184 | JZL 184: inhibits monoacylglycerol lipase; structure in first source | benzodioxoles | |
palmostatin b | palmostatin B: inhibits acyl protein thioesterase 1; structure in first source | ||
jzl195 | JZL195: inhibits both ​fatty-acid amide hydrolase 1 and ​monoglyceride lipase; structure in first source | ||
sar127303 | SAR127303: inhibits monoacylglycerol lipase; structure in first source | ||
palmostatin m | palmostatin M: inhibits acyl protein thioesterases 1 and 2; structure in first source | ||
mjn110 | MJN110: structure in first source |